S1 Fig Grade 2–4 Acute GVHD; S2 Fig Subgroup analysis among patients who received TBI conditioning.

Ramalingam, Sendhilnathan; Siamakpour-Reihani, Sharareh; Bohannan, Lauren; Ren, Yi; Sibley, Alexander; Sheng, Jeff; Ma, Li; Nixon, Andrew B.; Lyu, Jing; Parker, Daniel C.; Bain, James; Muehlbauer, Michael; Ilkayeva, Olga; Kraus, Virginia Byers; Huebner, Janet L.; Spitzer, Thomas; Brown, Jami; Peled, Jonathan U.; van den Brink, Marcel; Gomes, Antonio; Choi, Taewoong; Gasparetto, Cristina; Horwitz, Mitchell; Long, Gwynn; Lopez, Richard; Rizzieri, David; Sarantopoulos, Stefanie; Chao, Nelson; Sung, Anthony D.

doi:10.1371/journal.pone.0252995.s001

pone.0252995.s001.pptx (175.37 kB)

S1 Fig Grade 2–4 Acute GVHD; S2 Fig Subgroup analysis among patients who received TBI conditioning.

presentation

posted on 2021-06-25, 17:31 authored by Sendhilnathan Ramalingam, Sharareh Siamakpour-Reihani, Lauren Bohannan, Yi Ren, Alexander Sibley, Jeff Sheng, Li Ma, Andrew B. Nixon, Jing Lyu, Daniel C. Parker, James Bain, Michael Muehlbauer, Olga Ilkayeva, Virginia Byers Kraus, Janet L. Huebner, Thomas Spitzer, Jami Brown, Jonathan U. Peled, Marcel van den Brink, Antonio Gomes, Taewoong Choi, Cristina Gasparetto, Mitchell Horwitz, Gwynn Long, Richard Lopez, David Rizzieri, Stefanie Sarantopoulos, Nelson Chao, Anthony D. Sung

(A) Pasireotide did not reduce the rate of grade 3–4 GI toxicity, (B) Pasireotide did not reduce the rate of Grade 2–4 Acute GVHD; S3A Fig Kaplan-Meier curves for overall survival; S3B Fig Kaplan-Meier curves for relapse free survival.

(PPTX)